# Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy

> **NCT00619983** · PHASE4 · TERMINATED · sponsor: **Wake Forest University** · enrollment: 22 (actual)

## Conditions studied

- Diabetic Neuropathic Pain
- Chronic Low Back Pain

## Interventions

- **DRUG:** donepezil
- **DRUG:** duloxetine
- **DRUG:** donepezil 2.5 mg and duloxetine 30mg
- **DRUG:** placebo
- **DRUG:** gabapentin

## Key facts

- **NCT ID:** NCT00619983
- **Lead sponsor:** Wake Forest University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Study terminated due to low enrollment
- **Last updated:** 2018-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619983, "Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00619983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*